IWINF - Irwin Naturals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
1.2500
0.0000 (0.00%)
At close: 01:48PM EDT
Stock chart is not supported by your current browser
Previous Close1.2500
Open1.3390
BidN/A x N/A
AskN/A x N/A
Day's Range1.2500 - 1.2500
52 Week Range0.8000 - 3.9700
Volume12
Avg. Volume454
Market Cap2.248M
Beta (5Y Monthly)N/A
PE Ratio (TTM)125.00
EPS (TTM)0.0100
Earnings DateMay 25, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • GlobeNewswire

    Irwin Naturals Reports Year End 2022 Financial Results and Recent Events

    LOS ANGELES, May 25, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today reported its financial results for the fourth quarter and year ended December 31, 2022, on www.sedar.com. Financial Highlights for FY 2022 (all comparisons are for the year ended December 31 unless otherwise indicated): Annual revenue was $89.5 million, down 10.8% from $100.3 million in 2021. The decrease is primarily attributed to an overall decrease in business

  • CNW Group

    IIROC Trading Halt - IWIN

    The following issues have been halted by IIROC:

  • GlobeNewswire

    Update on Release of the 2022 Year End Financials and Board of Directors

    LOS ANGELES, May 03, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announces that the British Columbia Securities Commission has issued a failure-to-file-cease trade order (“CTO”) pursuant to National Policy 11-207 – Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions in respect of the securities of the Company as a result of the Company not having filed its annual financial statements and management’s discuss

  • GlobeNewswire

    Irwin Naturals Cannabis Products Launch Nationwide in Canada

    Company announces products being available nationwide through Starseed Medicinal Medical Platform Irwin Naturals Cannabis 25mg CBD Softgel Irwin Naturals Cannabis 25mg CBD Softgel LOS ANGELES, March 24, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), is proud to announce the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform. CBD 25mg Softgels

  • GlobeNewswire

    REPEAT - Irwin Naturals Acquires Ketamine Media

    Expanding Reach in Rapidly Growing Ketamine Therapy MarketLOS ANGELES, March 22, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is thrilled to announce the successful acquisition of Keta Media, LLC, dba Ketamine Media (“Ketamine Media”) as of March 17, 2023. Ketamine Media is the nation's foremost advertising company dedicated to raising awareness about the clinical use of ketamine. The agreement with Ketamine Media was initially annou

  • GlobeNewswire

    Irwin Naturals Acquires Ketamine Media

    Expanding Reach in Rapidly Growing Ketamine Therapy MarketLOS ANGELES, March 21, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is thrilled to announce the successful acquisition of Keta Media, LLC, dba Ketamine Media (“Ketamine Media”) as of March 17, 2023. Ketamine Media is the nation's foremost advertising company dedicated to raising awareness about the clinical use of ketamine. The agreement with Ketamine Media was initially annou

  • GlobeNewswire

    Update on LOI for Business Combination with Braxia Scientific Corp.

    LOS ANGELES, March 16, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”), announced today that it has terminated the non-binding amended and restated letter of intent ("LOI") for a business combination with Braxia Scientific Corp. ("Braxia"), (the "Proposed Transaction"). The Company's news release dated January 27, 2023, contained full details of the Proposed Transaction. CEO of Irwin Naturals, Klee Irwin, expressed disappointment on the

  • Newsfile

    Braxia Scientific Reports Q3 2023 Financial Results and Provides Update on Acquisition Under LOI with Irwin Naturals

    Braxia Health ketamine treatments up 29% YoY in Q3 2023 and revenue up 50.5% YoYToronto, Ontario--(Newsfile Corp. - March 1, 2023) - Braxia Scientific Corp. (CSE: BRAX) (OTC Pink: BRAXF) (FSE: 4960), ("Braxia Scientific", or the "Company"), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, today announced the filing of its financial statements and management discussion and analysis for the third

  • GlobeNewswire

    REPEAT - Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics

    LOS ANGELES, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is pleased to announce the Company has successfully completed the acquisition of Serenity Health, LLC, (“Serenity”) one of the leading ketamine clinics in Louisville, KY. The agreement with Serenity was initially announced November 30, 2022. The acquisition, completed on February 16, 2023, marks two key milestones in Irwin’s Emergence clinics growth strategy in the me

  • GlobeNewswire

    Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics

    LOS ANGELES, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) is pleased to announce the Company has successfully completed the acquisition of Serenity Health, LLC, (“Serenity”) one of the leading ketamine clinics in Louisville, KY. The agreement with Serenity was initially announced November, 30, 2022. The acquisition, completed on February 16, 2023, marks two key milestones in Irwin’s Emergence clinics growth strategy in the m

  • GlobeNewswire

    Irwin Naturals Secures $40 Million of Financing for its Current Operations including Psychedelic Mental Health Clinic Rollup, Potential for up to $60 Million

    LOS ANGELES, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that the Company has secured a credit facility as of February 1, 2023 with its existing commercial lender for up to $60 million with $40 million of it currently committed. The rate shall be variable based on the margins of the credit facilities. Half of the facility is in place until August 2024, with a maturity date of February 2028, while half of fac

  • GlobeNewswire

    Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific

    Strategic transaction assembles an experienced management and scientific team world-renowned in the mental health treatment, research and development.Establishes large footprint of 22 specialized mental health clinics across North America, enhanced by a telehealth platform expected to extend access to critical treatments for millions of people across multiple states in the US.Combined network of clinics creates a leading international mental health research platform for in-human clinical develop

  • Baystreet

    Stocks in play: Irwin Naturals Inc

    Announces it has entered into a non-binding amended and restated Letter of Intent for a business combination ...

  • GlobeNewswire

    Company announces licensing agreement with Oklahoma company to distribute Irwin Naturals Cannabis products

    LOS ANGELES, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing agreement with a partner in Oklahoma to produce and distribute Irwin Naturals THC products. Klee Irwin, CEO of Irwin Naturals said, “Oklahoma is a significant step in what is becoming a sprint to put Irwin Naturals THC products on the shelves of dispensaries in all 38 states where cannabis is legalized. We’re tremendously excited to reach t

  • GlobeNewswire

    Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US

    LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) , is proud to announce it has signed a Letter of Intent entering into a partnership with Braxia Scientific Corp. (“Braxia Scientific”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research company providing psychiatric, innovative ketamine and psilocybin treatments for mental health disorders, to launch Clinical Research Services across Irwin’s growing U.S. based

  • GlobeNewswire

    Irwin Naturals THC Products to Be Available in Oregon

    Company announces licensing agreement with Oregon company to distribute Irwin Naturals THC productsLOS ANGELES, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced on a licensing agreement with JV 805 LLC dba Hyphae Wellness (“Hyphae Wellness”), one of Oregon’s premier mushroom and cannabis product developers, to manufacture, sublicense and distribute Irwin Naturals THC products throughout that state. Klee Irwin, CEO of I

  • GlobeNewswire

    The Addition of Three Mental Health Clinics to Irwin Naturals' Florida Footprint Solidifies the Companies Impact as One of the Fastest-Growing Chains of Mental Health Clinics

    Company continues to expand its national network of psychedelic mental-healthcare clinicsLOS ANGELES, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) completed the acquisition of the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center. The Company entered into an acquisition agreement (the “Agreement”) dated October 30, 2022 with Clare Clinic, Inc., d/b/a Florida Mind Health Center, which serves clients out of three

  • GlobeNewswire

    Irwin Naturals Files Q3 2022 Financials

    Successful Execution on Ketamine ClinicRollup Strategy and Cannabis Licensing to Accelerate Future Growth LOS ANGELES, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced the Company filed results for its third quarter of fiscal 2022, the period ended September 30, 2022 on www.sedar.com. Sean Sand, CFO, stated, “Despite cost pressures continuing through the quarter, we were able to grow our Gross Margins by +4.8% over Q3

  • GlobeNewswire

    Irwin Naturals Leverages Household Brand Status in Effort to be World’s Largest Chain of Psychedelic Mental Health Clinics

    LOS ANGELES, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today it reached a binding, arms-length, agreement to acquire Serenity Health, LLC in Louisville, Kentucky, on November 25, 2022. The move continues Irwin’s national ketamine clinic rollup strategy that has seen the Company move quickly toward its goal of building Irwin Naturals Emergence into the world’s largest chain of psychedelic mental health clinics. I

  • GlobeNewswire

    Irwin Naturals Looks to Add Pacific Northwest Ketamine Clinic to Its National Footprint

    Planned addition of Washington facility would mark 17th Prospective clinic signed to join fast-growing network for psychedelic mental healthcareLOS ANGELES, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding, arm’s length agreement to acquire the assets of Tri-Cities Infusion & Wellness Clinic, PLLC on November 5, 2022 which is located in Kennewick, Washington. This will be the first facility in Washington fo

  • GlobeNewswire

    Irwin Naturals THC Products to be Available In Mississippi Dispensaries

    Company announces licensing agreement with Mockingbird Cannabis in new medical marijuana marketLOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today a licensing and supply agreement with Mockingbird Cannabis, LLC (“Mockingbird Cannabis”) to produce and distribute Irwin Naturals THC products in Mississippi. Klee Irwin, CEO of Irwin Naturals said, “For 28 years, we have safely cared for the health of our cu

  • GlobeNewswire

    Irwin Naturals Looks to Add to Florida Foothold in Expanding Chain of Healthcare Clinics

    Company continues to grow its national network of psychedelic mental-healthcare clinicsLOS ANGELES, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) entered into a binding agreement on October 30, 2022, to acquire the assets of Clare Clinic, Inc., d/b/a Florida Mind Health Center, which operates three healthcare clinics in Florida. The clinics are located in Gainesville, Tallahassee and Panama City, and offer ketamine-assisted t

  • GlobeNewswire

    Irwin Naturals Looks to Add to Florida Foothold, Expanding Chain of Healthcare Clinics

    Company keeps adding to national network of psychedelic mental-healthcare clinicsLOS ANGELES, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement to acquire Dura Medical, LLC, a clinic in Naples, Florida, which offers ketamine-infusion therapy among its options for cutting-edge treatment of mental health disorders. The clinic will be incorporated into Irwin Naturals Emergence, a fast-growing national

  • GlobeNewswire

    Irwin Naturals Agrees to Add Idaho Clinic to Its National Chain of Psychedelic Mental-Health Clinics

    Irwin Naturals Emergence announces acquisition agreement in Idaho, continuing national rollup of ketamine clinicsLOS ANGELES, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) has reached a binding agreement on September 30, 2022 to acquire Ketamine Infusions of Idaho, PLLC, which operates a clinic in Idaho Falls. The clinic will join Irwin Naturals Emergence, a fast-growing national chain of psychedelic mental-health clinics, wh

  • GlobeNewswire

    Irwin Naturals Acquiring Ketamine Media

    Nation’s Leading Growth Platform for Ketamine Clinics to Drive Expansion of Irwin’s Emergence Clinics ChainLOS ANGELES, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today announced a definitive agreement to purchase all of the issued and outstanding shares of Keta Media, LLC dba Ketamine Media (“Ketamine Media”), the nation’s leading growth platform for clinics offering ketamine-assisted therapy. With a global network dedic